Results 51 to 60 of about 14,081 (169)

Oligometastatic Disease Management: Finding the Sweet Spot

Frontiers in Oncology, 2020
Hematogenous dissemination represents a common manifestation of squamous cell carcinoma of the head and neck, and the recommended therapeutic options usually consist of systemically administered drugs with palliative intent.
Petr Szturz, Daan Nevens, Daan Nevens, Jan B. Vermorken, Jan B. Vermorken   +4 more
doaj   +1 more source

Predictive factors for oligometastatic versus non-oligometastatic involvement of the central nervous system by brain metastases from breast cancer.

, 2011
123 Background: To assess rates of oligometastatic (1-3 metastases) versus non-oligometastatic (4 or more) involvement of the central nervous system (CNS) from breast cancer and determine whether rates vary for different breast cancer subtypes ...
R. D. Rao, K. L. Griem, J. C. Marsh, S. Garg   +3 more
core   +1 more source

Treatment of oligometastatic disease in colorectal cancer: from molecular biology to multimodal strategies

Oncology Reviews
The management of oligometastatic colorectal cancer (OMD-CRC) has undergone a profound evolution, transforming what was once a uniformly fatal diagnosis into a clinical scenario in which long-term survival and even cure are attainable for a carefully ...
G. Arrichiello, A. Piccolo, F. Carlino, E. Franzese, A. Ventriglia, M. Annunziata, V. Patanè, M. De Siero, M. D. Bisceglia, M. Orditura   +9 more
doaj   +1 more source

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Lung Nodules: A Single Institution Series

Frontiers in Oncology, 2019
Aim: Lung metastases from an extra-pulmonary origin occasionally present with a limited metastatic disease burden. In cases where metastatectomy is not feasible, stereotactic body radiation therapy (SBRT) represents a non-invasive, efficacious option. We
Rodney E. Wegner, Stephen Abel, Shaakir Hasan, Lana Y. Schumacher, Athanasios Colonias   +4 more
doaj   +1 more source

Stereotactic Body Radiation Therapy: A Versatile, Well-Tolerated, and Effective Treatment Option for Extracranial Metastases From Primary Ovarian and Uterine Cancer

Frontiers in Oncology, 2020
PurposeSingle extracranial metastases from ovarian and uterine malignancies have historically been treated with surgery or conventional radiation. We report mature local control (LC), overall survival (OS), progression free survival (PFS), and toxicity ...
Nima Aghdam, Nima Aghdam, Michael C. Repka, Mary McGunigal, Abby Pepin, Ima Paydar, Sonali Rudra, Nitika Paudel, Monica Pernia Marin, Simeng Suy, Sean P. Collins, Willard Barnes, Brian T. Collins   +12 more
doaj   +1 more source

Surgical Removal of Residual Tumor Masses in Patients Undergoing Targeted Therapy for EGFR‐Mutated Locally Advanced or Metastatic Lung Cancer

International Journal of Cancer, Volume 159, Issue 9, Page 2244-2261, 1 November 2026.
Non‐small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations often exhibit significant tumor reduction following tyrosine kinase inhibitor (TKI) therapy. Residual tumors frequently remain, however, leading to drug resistance and disease progression.
Fedor Moiseenko, Daniil Stroyakovskiy, Evgeniy Levchenko, Mikhail Fedyanin, Albina Gabina, Ani Oganesian, Sergey Belukhin, Maria Stepanova, Ekaterina Stepanova, Elizaveta Artemyeva, Alexander Myslik, Nikita Volkov, Alexei Bogdanov, Tatiana Shuginova, Kirill Kryukov, Valeria Kheinshtein, Arif Allakhverdiev, Ivan Zaberegniy, Yana Akhmadiyarova, Mikhail Popov, Anastasiya Danilova, Dmitriy Sehniaidze, Nikita Savelov, Nikita Levchenko, Evgeniy Slugin, Olga Lopushanskaya, Ekaterina Kuligina, Svetlana Aleksakhina, Aglaya Iyevleva, Alexandr Ivantsov, Vladimir Moiseyenko, Evgeny Imyanitov   +31 more
wiley   +1 more source

Oligometastatic Prostate Cancer : Results of a Dutch Multidisciplinary Consensus Meeting

, 2020
Background: Oligometastatic prostate cancer (OMPC) is a heterogeneous disease state that is imperfectly understood, and its clinical implications are unclear.
Dutch Oligometastatic Prostate Cancer Working Group
core  

Oligometastatic Disease in Upper Gastrointestinal Cancer - How to Proceed

, 2017
<b><i>Background:</i></b> In the present study we review and discuss the current evidence and suggest how to proceed in the management of oligometastatic disease in upper gastrointestinal cancer.
Felix Berlth, Dirk L. Stippel, Felix Popp, Christiane J. Bruns, Christopher Betzler, Costanza Chiapponi, Patrick S. Plum   +6 more
core   +1 more source

Combination of Brachytherapy with Iodine-125 Seeds and Systemic Chemotherapy versus Systemic Chemotherapy Alone for Synchronous Extracranial Oligometastatic Non-Small Cell Lung Cancer

Cancer Management and Research, 2020
Huzi Li,1– 3 Zhendong Duan,2 Cheng Zhao,2 Wenyan Fang,2 Yingjie Jia,2 Xiaojiang Li,2 Fanming Kong,2 Lujun Zhao1 1Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key ...
Li H, Duan Z, Zhao C, Fang W, Jia Y, Li X, Kong F, Zhao L   +7 more
doaj  

Exceptional Locoregional Pathological Response in Metastatic Triple‐Negative Breast Cancer Treated With Palliative Platinum‐Based Chemotherapy

Clinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Locoregional pathological complete response with concurrent radiologic metabolic remission following palliative gemcitabine–carboplatin chemotherapy in young, low‐grade metastatic triple‐negative breast cancer patient suggests potential chemosensitivity in select advanced cases, warranting further clinical investigation.
Shristi Gupta, Abhisek Jha, Asmita Rayamajhi, Aron Neupane, Kshitiz Parajuli, Manash Jha   +5 more
wiley   +1 more source